Heat Biologics Statistics Share Statistics Heat Biologics has 25.66M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 25.66M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 24.26M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 825.04K, so 0% of the outstanding
shares have been sold short.
Short Interest 825.04K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 5.09
Valuation Ratios The PE ratio is -2.16 and the forward
PE ratio is null.
Heat Biologics's PEG ratio is
0.16.
PE Ratio -2.16 Forward PE n/a PS Ratio 36.17 Forward PS n/a PB Ratio 0.68 P/FCF Ratio 0 PEG Ratio 0.16
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Heat Biologics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 21.04,
with a Debt / Equity ratio of 0.01.
Current Ratio 21.04 Quick Ratio 21.04 Debt / Equity 0.01 Debt / EBITDA -0.05 Debt / FCF n/a Interest Coverage -277.27
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $43.12K Profits Per Employee $-722.47K Employee Count 49 Asset Turnover 0.02 Inventory Turnover n/a
Taxes Income Tax -145.97K Effective Tax Rate 0.41%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.3, so Heat Biologics's
price volatility has been higher than the market average.
Beta 0.3 52-Week Price Change n/a 50-Day Moving Average 2.65 200-Day Moving Average n/a Relative Strength Index (RSI) 40.02 Average Volume (20 Days) 155,104
Income Statement In the last 12 months, Heat Biologics had revenue of 2.11M
and earned -35.4M
in profits. Earnings per share was -1.41.
Revenue 2.11M Gross Profit 2.11M Operating Income -35.42M Net Income -35.4M EBITDA -35.55M EBIT -35.42M Earnings Per Share (EPS) -1.41
Full Income Statement Balance Sheet The company has 8.05M in cash and 1.67M in
debt, giving a net cash position of 6.38M.
Cash & Cash Equivalents 8.05M Total Debt 1.67M Net Cash 6.38M Retained Earnings -165.72M Total Assets 114.27M Working Capital 81.26M
Full Balance Sheet Margins Gross margin is 100%, with operating and profit margins of -1676.4% and -1675.54%.
Gross Margin 100% Operating Margin -1676.4% Pretax Margin -1682.44% Profit Margin -1675.54% EBITDA Margin -1682.44% EBIT Margin -1676.4% FCF Margin n/a
Dividends & Yields HTBX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for HTBX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 11, 2020. It was a
backward
split with a ratio of 1:7.
Last Split Date Dec 11, 2020 Split Type backward Split Ratio 1:7
Scores Altman Z-Score 1.54 Piotroski F-Score 1
